Nenad Grmusa

Company: DEM Biopharma

Job title: Chief Executive Officer

Seminars:

DEM Biopharma: Uncovering Targets Behind Mechanisms of Immune Evasion in Solid Organ Malignancies 4:30 pm

Discovering methods to promote a consistent macrophage phenotype and suppressing phenotype switching Reinforcing the importance of improving durability of phenotypes when working with macrophages Enhancing longevity of macrophages to prevent apoptosis from environmental factors by benchmarking effective practicesRead more

day: Conference Day One